Skip to content
DraconiticResearch
Search Sources API
224,311 studies31 sourcesUpdated 58 min ago

Oncology

5,695 studies449 in 7 days2,628 in 30 days

Filters
Type
Date
Clear

Latest

5,695 studies

  1. Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer
    Benoit Paquette, Hélène Therriault, Isabelle Gauthier +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  2. PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma
    Yekai Feng, Yonghang Zhang, Haibo Ou +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  3. Anticancer activity of asiatic acid in cisplatin-resistant human neuroblastoma SH-SY5Y and its unaffected effect on human neural stem cells
    Apisada Jiso, Laphatrada Yurasakpong, Amarin Thongsuk +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  4. Prognostic value of melatonin-related signature genes in lung adenocarcinoma
    Hongxia Guo, Lixia Liu, Ying Lu +3
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  5. Does acute inflammation triggered by infection promote cancer progression?
    Felipe Valença-Pereira, Bryan Johnson, James DeGregori +1
    PLOS BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  6. Enhancing early-stage breakthrough technology identification: A CatBoost model optimized with the SABO algorithm
    Ming Lei, Yin Yu
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  7. Modelling the impact of physical activity on MASLD in Saudi Arabia
    Carolyn Wallace, Saleh A. Alessy, Faisal Abaalkhail +20
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPhysiologyPLOS
  8. Spatial compartmentalization of melanoma cell states reveals CAF-associated tumor cells with enhanced proliferative capacity
    Weilong Zheng, Huanhuan Zheng
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  9. Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids
    Miguel Martínez Lozano, Heinz D. Wanzenboeck, Sonia Prado-López
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  10. Multi-site observational evaluation of Breast AI™-supported ultrasound risk stratification in breast cancer assessment pathways
    Kathryn Malherbe, Carol A. Benn, Gerhard Botha
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  11. Factors affecting task shifting/sharing from physicians to pharmacists in cancer chemotherapy in Japan: A qualitative study
    Keiko Ikuta, Atsushi Yonezawa, Hiroshi Okada +6
    PLOS OnePeer-reviewedCC BY 4.0OncologyPLOS
  12. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedOncologyHAL
  13. NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer
    Marayke Mayrata, Alvaro Lopez-Sanchez, Esteban Urriolabeitia +5
    Journal of Inorganic BiochemistryPeer-reviewedLicence not stated1 citedOncologyHAL
  14. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
    Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam +10
    Chemical ReviewsPeer-reviewedCC BY-NC-ND 4.0Full text25 citedOncologyHAL
  15. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
    Ruoping Tang, Anne-Marie Faussat, Jean-Yves Perrot +6
    BMC CancerPeer-reviewedCC BY 4.0Full text66 citedOncologyPharmacology & toxicologyHAL
  16. PP2A Cdc55 Phosphatase Imposes Ordered Cell-Cycle Phosphorylation by Opposing Threonine Phosphorylation
    Molly Godfrey, Sandra Touati, Meghna Kataria +3
    Molecular CellPeer-reviewedCC BYFull text105 citedOncologyHAL
  17. Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
    Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDOncologyHAL
  18. Uveal melanoma: In the era of new treatments
    Wespiser Mylène, E. Neidhardt, S. Negrier
    Cancer Treatment ReviewsPeer-reviewedLicence not stated55 citedOncologyHAL
  19. Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer
    Ke Zhou, Germán Cano-Sancho, Caroline Goupille +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  20. Treatment sequences in EGFR mutant advanced NSCLC
    Wespiser Mylène, A. Swalduz, M. Pérol
    Lung CancerPeer-reviewedLicence not statedFull text16 citedOncologyHAL
  21. Colonic Metastases from Lung Adenocarcinoma Detected During an Evaluation of Recurrent Diarrhea Associated with Immune-Related Colitis
    Naohito Hashimoto, Yoshiaki Nagai, Konjo Cho +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  22. Neutrophil-to-lymphocyte Ratio as a Prognostic Indicator in Patients with Nursing and Healthcare-associated Pneumonia: A Retrospective Study
    Yuki Hiraoka, Takashi Ogasawara, Ei Kishimoto +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  23. Antigen-Guided Synthetic Receptor Engineering for Safer T Cell Immunotherapy in Solid Tumors
    Su-Jin Kang, Hyo Jung Cho, Ji-Hyeon Kim +1
    Immune NetworkPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  24. Management of diarrhea in patients receiving liposomal irinotecan-based regimens: a narrative review of mechanisms, clinical impact, and evidence-based strategies.
    Alberto Zaniboni
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  25. Pt(iv) scaffold effects on nucleolar stress and DNA damage response pathways
    Christopher R. Griffin, Victoria J. DeRose
    RSC Chemical BiologyPeer-reviewedCC BY-NC 3.0Full textOncologyPMC